FindTrial
Sign In

A study for the Safety and efficacy of laparoscopic microwave ablation in the treatment of giant hepatic haemangioma

The Safety and efficacy of laparoscopic microwave ablation for giant hepatic haemangioma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018679
Enrollment
Unknown
Registered
2018-10-03
Start date
2014-01-01
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic haemangioma

Interventions

LWMA:laparoscopic microwave ablation
ORES:conventional open resection

Sponsors

Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. definite diagnosis of a giant hemangioma (= 5 cm) based on at least two coincidental radiological findings on enhanced CT/MRI or contrast-enhanced ultrasound; 2. absence of clinical symptoms that are typically caused by giant hemangioma excluding the presence of other hepatobiliary or gastrointestinal disorders; 3. patient was anxious and insisted on a surgical treatment.

Exclusion criteria

Exclusion criteria: 1. patients who did not give informed consent; 2. patients with other types of solid liver tumors; 3. pregnant patients.

Design outcomes

Primary

MeasureTime frame
Tumor size;—

Countries

China

Contacts

Public ContactJun Xiong

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

oldxiong@163.com+86 13995536848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026